We’ve Spent All Week Talking Drugs
A Fall 2023 report from Pitchbook, a financial data firm, shows that Ozempic and its counterparts — WeGovy, Mounjaro, and other semaglutides — are doing more to the health economy than helping people lose weight.
For the record — I’m not against weight loss drugs, so long as people use them wisely and ha…
